Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method
Rolf Teschke, Nahúm Méndez‐Sánchez, Axel Eickhoff
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4828-4828
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Aluminum, Arsenic, Beryllium, Cadmium, Chromium, Cobalt, Copper, Iron, Lead, Mercury, Molybdenum, Nickel, Platinum, Thallium, Titanium, Vanadium, and Zinc: Molecular Aspects in Experimental Liver Injury
Rolf Teschke
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12213-12213
Open Access | Times Cited: 92
Persistent hepatocyte secretory failure in lopinavir/ritonavir related to drug-induced liver injury: a case report
Yue Sun, Ran Wang, C.L. Wang, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 1
Myeloid‐Mas Signaling Modulates Pathogenic Crosstalk among MYC+CD63+ Endothelial Cells, MMP12+ Macrophages, and Monocytes in Acetaminophen‐Induced Liver Injury
Daiwen Chen, Zhi Lü, Yudong Zhao, et al.
Advanced Science (2024) Vol. 11, Iss. 16
Open Access | Times Cited: 8
Treatment of Drug-Induced Liver Injury
Rolf Teschke
Biomedicines (2022) Vol. 11, Iss. 1, pp. 15-15
Open Access | Times Cited: 27
The pathological mechanism of the COVID-19 convalescence and its treatment with traditional Chinese medicine
Linlin Jiang, Xuedong An, Yingying Duan, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 16
Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use
Rolf Teschke, Gaby Danan
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10855-10855
Open Access | Times Cited: 14
Drug‐induced liver injury as assessed by the updated Roussel Uclaf Causality Assessment Method following mild COVID‐19 in a patient under anastrozole therapy—A case report
Wolfgang Lischka, Gernot Kriegshäuser
Cancer Reports (2024) Vol. 7, Iss. 4
Open Access | Times Cited: 4
Interplay Between Drug-Induced Liver Injury and Gut Microbiota: A Comprehensive Overview
Guolin Li, Yifu Hou, Changji Zhang, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 18, Iss. 3, pp. 101355-101355
Open Access | Times Cited: 4
COVID-19: Has the Liver Been Spared?
Nicolò Brandi, Daniele Spinelli, Alessandro Granito, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1091-1091
Open Access | Times Cited: 10
Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations
Rolf Teschke
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6663-6663
Open Access | Times Cited: 10
The Effect of Potentially Hepatotoxic Medicinal Products on Alanine Transaminase Levels in COVID-19 Patients: A Case–Control Study
В. И. Петров, A. Yu. Ryazanova, N. S. Tokareva
Safety and Risk of Pharmacotherapy (2025)
Open Access
Antibiotics enhancing drug-induced liver injury assessed for causality using Roussel Uclaf Causality Assessment Method: Emerging role of gut microbiota dysbiosis
Lihong Fu, Yihan Qian, Zhi Shang, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 14
Thromboembolic Disease and Cardiac Thrombotic Complication in COVID-19: A Systematic Review
Francesco Nappi, Pierluigi Nappi, Ivancarmine Gambardella, et al.
Metabolites (2022) Vol. 12, Iss. 10, pp. 889-889
Open Access | Times Cited: 12
Impact of COVID-19 in individuals with and without pre-existent digestive disorders with a particular focus on elderly patients
Alfredo Papa, Marcello Covino, Sara Sofia De Lucia, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 26, pp. 4099-4119
Open Access | Times Cited: 7
Idiosyncratic DILI and RUCAM under One Hat: The Global View
Rolf Teschke, Gaby Danan
Livers (2023) Vol. 3, Iss. 3, pp. 397-433
Open Access | Times Cited: 7
Liver injury in COVID-19: an insight into pathobiology and roles of risk factors
Abbas Tazarghi, Sahar Bazoq, M H Taziki, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Liver injury in patients with COVID-19 in comparison to patients with the pandemic influenza A (H1N1) 2009: a population-based study
Jokull Sigurdarson, Elías Eyþórsson, Agnar Bjarnason, et al.
Scandinavian Journal of Gastroenterology (2023) Vol. 58, Iss. 10, pp. 1145-1152
Closed Access | Times Cited: 5
Clinical evidence of three traditional Chinese medicine drugs and three herbal formulas for COVID-19: A systematic review and meta-analysis of the Chinese population
Liangzhen You, Qianqian Dai, Xiao-ying Zhong, et al.
Journal of Integrative Medicine (2023) Vol. 21, Iss. 5, pp. 441-454
Closed Access | Times Cited: 5
Drug-Induced Liver Injury in Hospitalized Patients during SARS-CoV-2 Infection
Eleni Karlafti, Daniel Paramythiotis, Konstantina Pantazi, et al.
Medicina (2022) Vol. 58, Iss. 12, pp. 1848-1848
Open Access | Times Cited: 9
COVID-19-Associated Liver Injury
Daniel T Gildea, Stephanie Woo, Corinne E O'Connor, et al.
Hepatic Medicine Evidence and Research (2023) Vol. Volume 15, pp. 1-9
Open Access | Times Cited: 4
COVID-19 and the Liver: A Complex and Evolving Picture
Simon D. Taylor‐Robinson, Marsha Y. Morgan
Hepatic Medicine Evidence and Research (2023) Vol. Volume 15, pp. 209-220
Open Access | Times Cited: 4
Highlights of the drug-induced liver injury literature for 2021
Stephanie Woo, Dalal Alhaqqan, Daniel T Gildea, et al.
Expert Review of Gastroenterology & Hepatology (2022) Vol. 16, Iss. 8, pp. 767-785
Closed Access | Times Cited: 7
Liver tests abnormalities with licensed antiviral drugs for COVID-19: a narrative review
Giacomo Casalini, Andrea Giacomelli, Spinello Antinori
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 12, pp. 1483-1494
Closed Access | Times Cited: 7
Liver involvement in patients with COVID-19 infection: A comprehensive overview of diagnostic imaging features
Davide Ippolito, Cesare Maino, Federica Vernuccio, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 5, pp. 834-850
Open Access | Times Cited: 2
Role of oxidative stress and endoplasmic reticulum stress in drug-induced liver injury
Hanghang Wu, Xiyuan Bao, Alejandro H. Gutierrez, et al.
(2023), pp. 83-99
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top